Drug Point Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 31-10-2024
- Paid Up Capital ₹ 0.50 M
as on 31-10-2024
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 14.52%
(FY 2023)
- Profit 131.47%
(FY 2023)
- Ebitda -76.54%
(FY 2023)
- Net Worth 32.12%
(FY 2023)
- Total Assets 67.39%
(FY 2023)
About Drug Point
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Anupam Kumar, Rakesh Ranjan, Namita Kumari, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230BR2020PTC045902
- Company No.
045902
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Drug Point Private Limited offer?
Drug Point Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, Oxygen Mask, Hand Sanitizers & Personal Hygiene, Hand Sanitizer & Disinfectant, Nutraceuticals & Dietary Supplements, Multivitamin Tablets & Capsules, Cleaning Liquids & Wipes, Disinfectant Spray, Common Disease Medicines, Pharmaceutical Capsules.
Who are the key members and board of directors at Drug Point?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Namita Kumari  | Director | 20-Apr-2020 | Current |
| Anupam Kumar | Director | 29-Sep-2022 | Current |
| Rakesh Ranjan | Additional Director | 15-Jan-2023 | Current |
| Srishti Nayyar | Director | 20-Apr-2020 | Current |
Financial Performance of Drug Point.
Drug Point Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.52% increase. The company also saw a substantial improvement in profitability, with a 131.47% increase in profit. The company's net worth Soared by an impressive increase of 32.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Drug Point?
Unlock access to Drug Point's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Beorganic Food And Pharma Private LimitedActive 4 years 5 months
Anupam Kumar and Rakesh Ranjan are mutual person
- Magadh Steel And Cement Private LimitedActive 4 years 6 months
Anupam Kumar and Rakesh Ranjan are mutual person
- Royal Nest Homes Private LimitedActive 10 years 3 months
Anupam Kumar and Rakesh Ranjan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Drug Point?
Drug Point has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Drug Point, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Drug Point's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
